Anula Jayasuriya

Dr. Jayasuriya is the founder and managing editor of EXXclaim Capital, an early-stage venture fund focused on catalyzing innovation, entrepreneurship, and investment in women’s health, and a co-founder of Evolvence India Life Science Fund (EILSF), the very first fund in India to focus exclusively on health care and invest in Indian pharmaceutical, biotechnology, medical device, and contract services companies. She has applied deep business, scientific, and medical knowledge in her career as a pharmaceutical company executive, private equity executive, and venture capitalist, providing her with a broad experience base spanning clinical, executive, entrepreneurial, and financial roles. In 2006, Dr. Jayasuriya co-founded EILSF, focusing exclusively on investment in Indian pharmaceutical, biotechnology, medical device, and contract services companies. Dr. Jayasuriya was previously a partner with Skyline Ventures in Palo Alto, and prior to that with the German/US venture capital firm TVM in San Francisco. Her prior positions include VP Business Development at Genomics Collaborative Inc.; Vice President, Global Drug Development at Hoffman-La Roche for opportunistic infections in AIDS and Transplantation; and Director, Outcomes Research at Syntex Laboratories.